Clin Lymphoma Myeloma. 2010;10(4):278-280. Our study has several limitations. Clinical information on the patients studied was incomplete, in part because half of the serum specimens came from ...

Monoclonal gammopathy of undetermined significance (MGUS) is an abnormal finding of a blood test. It means there’s a specific protein present in your blood and is an early sign of certain types of a ...

Serum protein electrophoresis (SPEP) is a clinical tool used to screen for monoclonal gammopathy, thus it is a critical tool in the evaluation of patients with multiple myeloma. However, SPEP ...

The rate of MGUS among hospitalized patients over 50 was twice as high as that of the same age group in the general population. Higher rates of MGUS were prevalent among patients who had elevated ...

This transcript has been edited for clarity. Joseph Mikhael, MD: Hello. My name is Dr Joseph Mikhael, and welcome to Medscape InDiscussion: Multiple Myeloma. Today we're talking about screening for ...

Antigen-driven selection has been implicated in the pathogenesis of monoclonal gammopathies. Patients with Gaucher’s disease have an increased risk of monoclonal gammopathies. Here we show that the ...

The risk for patients with monoclonal gammopathy of undetermined significance developing multiple myeloma is double if they have a specific category of rheumatic diseases compared with those without ...

Multiple myeloma is often preceded by a precursor disease, such as monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma. However, patients with a myeloma precursor disease ...

Individuals with low-risk or intermediate-risk monoclonal gammopathy of undetermined significance (MGUS) may convert to high-risk MGUS and progress to multiple myeloma within 5 years, researchers ...